1. Advances in targeted therapy for acute myeloid leukaemia. (28th November 2017) Authors: Kayser, Sabine; Levis, Mark J. Journal: British journal of haematology Issue: Volume 180:Number 4(2018) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation. Issue 2 (28th September 2017) Authors: Fathi, Amir T.; Blonquist, Traci M.; Hernandez, Daniela; Amrein, Philip C.; Ballen, Karen K.; McMasters, Malgorzata; Avigan, David E.; Joyce, Robin; Logan, Emma K.; Hobbs, Gabriela; Brunner, Andrew M.; Joseph, Christelle; Perry, Ashley M.; Burke, Meghan; Behnan, Tanya; Foster, Julia; Bergeron, Me... Journal: Cancer Issue: Volume 124:Issue 2(2018) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. (2nd February 2021) Authors: Kayser, Sabine; Hills, Robert K.; Langova, Ralitsa; Kramer, Michael; Guijarro, Francesca; Sustkova, Zuzana; Estey, Elihu H.; Shaw, Carole M.; Ráčil, Zdeněk; Mayer, Jiri; Zak, Pavel; Baer, Maria R.; Brunner, Andrew M.; Szotkowski, Tomas; Cetkovsky, Petr; Grimwade, David; Walter, Roland B.; Burnett... Journal: British journal of haematology Issue: Volume 192:Number 5(2021) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical implications of molecular markers in acute myeloid leukemia. (23rd October 2018) Authors: Kayser, Sabine; Levis, Mark J. Journal: European journal of haematology Issue: Volume 102:Number 1(2019) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clustered incidence of adult acute promyelocytic leukemia in the vicinity of Baltimore. Issue 11 (18th September 2020) Authors: Li, Andrew Y.; Kashanian, Sarah M.; Hambley, Bryan C.; Zacholski, Kyle; Baer, Maria R.; Duong, Vu H.; El Chaer, Firas; Holtzman, Noa G.; Norsworthy, Kelly J.; Levis, Mark J.; Smith, B. Douglas; Kamangar, Farin; Ghiaur, Gabriel; Emadi, Ashkan Journal: Leukemia & lymphoma Issue: Volume 61:Issue 11(2020) Page Start: 2743 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Differentiation syndrome with lower‐intensity treatments for acute myeloid leukemia. Issue 6 (18th March 2021) Authors: Fathi, Amir T.; Stein, Eytan M.; DiNardo, Courtney D.; Levis, Mark J.; Montesinos, Pau; de Botton, Stéphane Journal: American journal of hematology Issue: Volume 96:Issue 6(2021) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Emerging molecular predictive and prognostic factors in acute myeloid leukemia. Issue 9 (2nd September 2018) Authors: McCurdy, Shannon R.; Levis, Mark J. Journal: Leukemia & lymphoma Issue: Volume 59:Issue 9(2018) Page Start: 2021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction. (August 2019) Authors: Hambley, Bryan C.; Norsworthy, Kelly J.; Jasem, Jagar; Zimmerman, Jacquelyn W.; Shenderov, Eugene; Webster, Jonathan A.; Showel, Margaret M.; Gondek, Lukasz P.; Dalton, William B.; Prince, Gabrielle; Gladstone, Douglas E.; Streiff, Michael B.; Pratz, Keith W.; Gojo, Ivana; Ghiaur, Gabriel; Levis,... Journal: Leukemia research Issue: Volume 83(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations. Issue 2 (February 2014) Authors: Kayser, Sabine; Levis, Mark J. Journal: Leukemia & lymphoma Issue: Volume 55:Issue 2(2014:Feb.) Page Start: 243 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Issue 8 (3rd July 2022) Authors: Karantanos, Theodoros; Tsai, Hua-Ling; Gondek, Lukasz P.; DeZern, Amy E.; Ghiaur, Gabriel; Dalton, W. Brian; Gojo, Ivana; Prince, Gabrielle T.; Webster, Jonathan; Ambinder, Alexander; Smith, B. Douglas; Levis, Mark J.; Varadhan, Ravi; Jones, Richard J.; Jain, Tania Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 1942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗